One child was found to have experienced oligomenorrhea - a prolactin-related adverse event – following treatment with risperidone [41], but analysis was inconclusive as to the relative risk of this event between groups (RR 0.97, CI 0.89 to 1.05, p = 0.44). Here, PRL is linked to Oligomenorrhea.